glp-1 news 2025 november You've probably seen the about the recent TrumpRx announcement — here's what it actually means if you're on or considering GLP-1s 👇 The deal between TrumpRx, Eli Lilly, and Novo Nordisk GLP-1 Agonists For Obesity In

Brierley DI, de Lartigue G

Sobo Semaglutide Dr

Obesity is considered to be related to increased appetite, changes in the levels of gastrointestinal hormones, increased fat mass, and disorders of satiety and satiation mechanisms (168)

She has over 20 years of experience in integrative and functional nutrition and has given lectures to health professionals and consumers on nutrition, dietary supplements and related health issues

Many patients lose 20% or more of their starting body weight, which represents a transformative result

For more background on GLP-1 science and medical context, read a clinical overview of semaglutide here: Real-world effectiveness: what reviews and studies say Evidence base for injectable semaglutide and tirzepatide is robust, showing substantial weight loss in trials and real-world use